The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches.

Saved in:
Bibliographic Details
Title: The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches.
Authors: Wu, Mingwei1 (AUTHOR), Chen, Yiyuan2 (AUTHOR), Hua, Gao2 (AUTHOR), Chunhui, Liu2 (AUTHOR) ttyylch@163.com
Source: Immunity, Inflammation & Disease. Oct2023, Vol. 11 Issue 10, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20504527
DOI:10.1002/iid3.1022